Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies
Clinical trial NCT03642496 · UNKNOWN
Trial details
- NCT number
- NCT03642496
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-19
- Primary completion
- 2020-08-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.